Equipment and technology
Top centres are equipped with advanced endocrine labs, continuous glucose monitoring, nuclear medicine (for thyroid) and pituitary/adrenal imaging; infrastructure is broadly comparable with international standards.

Explore hospitals in our directory that appear in Fudan University’s 2023 top-ten specialty rankings related to this health area. Each card identifies the specialty and position that connects the hospital to this category.
If you are researching endocrinology & metabolism care in China or endocrinology & metabolism treatment in China for yourself or a family member, the practical question is simple: how does care here compare with the best centres abroad? Below is a grounded, numbers-based comparison written for international patients.
China’s leading endocrine centres — Ruijin Hospital of Shanghai Jiao Tong University (ranked #1 in Fudan endocrinology for consecutive years), Peking Union Medical College Hospital and West China Hospital — sit in the country’s first tier, especially for diabetes, thyroid and pituitary disease. As an international benchmark, Mayo Clinic — ranked #1 in the US for diabetes and endocrinology by U.S. News — remains a global reference.
Top centres are equipped with advanced endocrine labs, continuous glucose monitoring, nuclear medicine (for thyroid) and pituitary/adrenal imaging; infrastructure is broadly comparable with international standards.
China has the world’s largest diabetes population — about 148 million adults in 2024 — so diabetes and metabolic care volumes at major centres are enormous. Thyroid, pituitary and adrenal disease management is standard at the top centres. Relative gaps remain in the very newest metabolic therapeutics and in clinical-trial infrastructure versus Mayo and similar institutions.
Standard endocrine medications — insulin, GLP-1 agonists, thyroid and osteoporosis drugs — are widely available and inexpensive; the newest agents (e.g., latest GLP-1s) can reach China later than the US/EU — verify per drug.
China has a large endocrinology workforce with many clinicians trained internationally; research output is growing. International leaders still set more original research and guidelines, but the gap is narrowing.
| Metric | China | Global benchmark | Read |
|---|---|---|---|
| Adults with diabetes (China, 2024) | ~148 million (largest nationally) | US ~38.5 million | China largest by count |
| Diabetes & endocrine care volume | Enormous at top centres | Mayo sets the standard | Large scale, comparable quality |
China adult diabetes ~148 million in 2024 (IDF Diabetes Atlas, 11th edition); US ~38.5 million.
Endocrinology and diabetes care in China typically cost a fraction of US/EU prices — a core reason international patients consider diabetes treatment in China.
At most top centres, waits for consultation and common procedures are shorter than in many public systems; international patient departments usually offer expedited booking.
Major centres run international clinics with English-speaking coordinators and self-pay / commercial insurance handling — directly relevant if you are weighing best hospitals for diabetes in China.
Yes. Major endocrine centres regularly treat international patients, and many have dedicated international departments. Suitability is decided case by case by the treating endocrinologist.
Yes. American patients commonly travel to China for planned diabetes or thyroid care, often for lower cost and shorter waits. Bring your records and allow time for translation and coordination.
The largest tertiary centres and their international departments provide English-speaking doctors and coordinators. For other settings, a medical interpreter or coordinator such as Wellward China is recommended.
Through a hospital international clinic, a local coordinator, or by contacting a service like Wellward China with your records and goals. Appointments at top centres can often be arranged faster than in many public systems.
A comparable course of care is typically a fraction of US prices in China, largely because of lower hospital and staffing costs and widely available generics (including insulin). Exact figures vary by medication regimen and hospital — request a written quote per case.
US prices reflect hospital charges, specialist fees, insurance administration and high drug costs. That gap is exactly why some international patients explore diabetes treatment in China as a pragmatic alternative.
For common, high-prevalence endocrine needs — diabetes, thyroid, metabolic disease — China’s top centres are highly competitive on cost, access and the sheer scale of experience. For the very newest metabolic therapeutics, China can be an efficient, pragmatic option, ideally combined with an international second opinion.
Endocrinology is the main ranking link. Nephrology and Cardiovascular Medicine are shown only as supplementary links for selected complications or overlapping concerns. The Chinese labels below follow the names shown in the Fudan specialty rankings.
Direct primary association for hormone, diabetes and metabolic conditions.
May be relevant when a diabetes or metabolic concern involves kidney complications.
May be relevant when a diabetes or metabolic concern involves cardiovascular complications.
Cards merge hospitals that appear in more than one relevant specialty list. Each badge keeps its specialty and rank visible; none of the positions is a cross-specialty overall ranking.
The relevant specialty depends on the patient’s records, symptoms and goals. Browse the hospital directory or contact us to discuss practical information and coordination options.
Share your question, relevant records and intended travel timing. We can explain possible coordination steps.
Talk to a Concierge →